Intervention

LABA

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting0

Common conditions3

Lead sponsors shown5

Clinical trials

6 shown

Effects of Acute Long-acting Bronchodilation on Oxygenation and Peripheral Ventilation in COPDNCT05927155 · 2021-06-15

INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice DesignNCT03467425 · 2018-04-11

Longitudinal Cohort Study in Participants With Severe Asthma to Assess BiomarkersNCT02537691 · 2015-08-28

Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD RegimenNCT01985334 · 2014-02-14

A Study to Evaluate the Safety and Use of Human Rhinovirus in Healthy and Asthmatic Participants (MK-0000-218)NCT01866306 · 2013-10-22

A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent AsthmaNCT01948401 · 2013-07-01

Common conditions

Asthma3 Pulmonary Disease, Chronic Obstructive2 COPD1

Leading sponsors

Hoffmann-La Roche2 Erasme University Hospital1 GlaxoSmithKline1 Merck Sharp & Dohme LLC1 Novartis Pharmaceuticals1

Trial status mix

COMPLETED6

Phase mix

PHASE43

PHASE11

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.